Annual D&A
$13.24 M
+$783.00 K+6.28%
December 31, 2022
Summary
- As of February 23, 2025, SRNE annual depreciation & amortization is $13.24 million, with the most recent change of +$783.00 thousand (+6.28%) on December 31, 2022.
- During the last 3 years, SRNE annual D&A has risen by +$2.26 million (+20.53%).
- SRNE annual D&A is now at all-time high.
Performance
SRNE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$3.59 M
-$30.00 K-0.83%
June 30, 2023
Summary
- As of February 23, 2025, SRNE quarterly depreciation & amortization is $3.59 million, with the most recent change of -$30.00 thousand (-0.83%) on June 30, 2023.
- Over the past year, SRNE quarterly D&A has dropped by -$30.00 thousand (-0.83%).
- SRNE quarterly D&A is now -0.83% below its all-time high of $3.62 million, reached on March 31, 2023.
Performance
SRNE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$13.93 M
+$357.00 K+2.63%
June 30, 2023
Summary
- As of February 23, 2025, SRNE TTM depreciation & amortization is $13.93 million, with the most recent change of +$357.00 thousand (+2.63%) on June 30, 2023.
- Over the past year, SRNE TTM D&A has increased by +$357.00 thousand (+2.63%).
- SRNE TTM D&A is now at all-time high.
Performance
SRNE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
SRNE Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.3% | -0.8% | +2.6% |
| 3 y3 years | +20.5% | -0.8% | +2.6% |
| 5 y5 years | +85.6% | -0.8% | +2.6% |
SRNE Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6.3% | -0.8% | +25.7% | at high | +11.8% |
| 5 y | 5-year | at high | +20.5% | -0.8% | +62.1% | at high | +31.7% |
| alltime | all time | at high | >+9999.0% | -0.8% | >+9999.0% | at high | >+9999.0% |
Sorrento Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $3.59 M(-0.8%) | $13.93 M(+2.6%) |
| Mar 2023 | - | $3.62 M(+8.1%) | $13.57 M(+2.5%) |
| Dec 2022 | $13.24 M(+6.3%) | $3.35 M(-0.1%) | $13.24 M(+3.9%) |
| Sep 2022 | - | $3.36 M(+3.8%) | $12.75 M(-1.5%) |
| Jun 2022 | - | $3.24 M(-1.9%) | $12.94 M(+0.8%) |
| Mar 2022 | - | $3.30 M(+15.4%) | $12.84 M(+3.0%) |
| Dec 2021 | $12.46 M(+13.2%) | $2.86 M(-19.4%) | $12.46 M(+5.4%) |
| Sep 2021 | - | $3.55 M(+13.0%) | $11.82 M(+3.6%) |
| Jun 2021 | - | $3.14 M(+7.5%) | $11.41 M(+5.0%) |
| Mar 2021 | - | $2.92 M(+31.6%) | $10.87 M(-1.3%) |
| Dec 2020 | $11.01 M(+0.2%) | $2.22 M(-29.3%) | $11.01 M(-4.5%) |
| Sep 2020 | - | $3.14 M(+20.9%) | $11.53 M(+7.7%) |
| Jun 2020 | - | $2.60 M(-15.1%) | $10.71 M(+1.2%) |
| Mar 2020 | - | $3.06 M(+11.6%) | $10.58 M(-3.8%) |
| Dec 2019 | $10.99 M(+15.7%) | $2.74 M(+18.5%) | $10.99 M(-4.9%) |
| Sep 2019 | - | $2.31 M(-6.0%) | $11.55 M(+0.5%) |
| Jun 2019 | - | $2.46 M(-29.0%) | $11.50 M(+4.9%) |
| Mar 2019 | - | $3.47 M(+5.1%) | $10.96 M(+15.4%) |
| Dec 2018 | $9.49 M(+33.0%) | $3.30 M(+46.0%) | $9.49 M(+17.8%) |
| Sep 2018 | - | $2.26 M(+17.4%) | $8.06 M(+2.3%) |
| Jun 2018 | - | $1.93 M(-3.9%) | $7.88 M(+2.5%) |
| Mar 2018 | - | $2.00 M(+7.4%) | $7.69 M(+7.7%) |
| Dec 2017 | $7.14 M(+147.4%) | $1.87 M(-10.4%) | $7.14 M(+3.0%) |
| Sep 2017 | - | $2.08 M(+20.1%) | $6.93 M(+39.4%) |
| Jun 2017 | - | $1.73 M(+19.3%) | $4.97 M(+31.0%) |
| Mar 2017 | - | $1.45 M(-12.5%) | $3.79 M(+31.5%) |
| Dec 2016 | $2.88 M | $1.66 M(+1262.3%) | $2.88 M(+64.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $122.00 K(-78.1%) | $1.76 M(-14.1%) |
| Jun 2016 | - | $556.00 K(+2.0%) | $2.04 M(-2.3%) |
| Mar 2016 | - | $545.00 K(+2.3%) | $2.09 M(-11.7%) |
| Dec 2015 | $2.37 M(-25.6%) | $533.00 K(+30.0%) | $2.37 M(-10.5%) |
| Sep 2015 | - | $410.00 K(-32.1%) | $2.65 M(-13.0%) |
| Jun 2015 | - | $604.00 K(-26.6%) | $3.04 M(-5.8%) |
| Mar 2015 | - | $823.00 K(+1.4%) | $3.23 M(+1.5%) |
| Dec 2014 | $3.18 M(+146.8%) | $812.00 K(+0.9%) | $3.18 M(+5.3%) |
| Sep 2014 | - | $805.00 K(+1.5%) | $3.02 M(+19.6%) |
| Jun 2014 | - | $793.00 K(+2.5%) | $2.53 M(+28.9%) |
| Mar 2014 | - | $774.00 K(+18.7%) | $1.96 M(+52.0%) |
| Dec 2013 | $1.29 M(+340.3%) | $652.00 K(+111.0%) | $1.29 M(+78.7%) |
| Sep 2013 | - | $309.00 K(+36.7%) | $722.00 K(+47.3%) |
| Jun 2013 | - | $226.00 K(+119.4%) | $490.10 K(+47.0%) |
| Mar 2013 | - | $103.00 K(+22.6%) | $333.50 K(+13.8%) |
| Dec 2012 | $293.00 K(+84.0%) | $84.00 K(+8.9%) | $293.00 K(+10.9%) |
| Sep 2012 | - | $77.10 K(+11.1%) | $264.20 K(+12.9%) |
| Jun 2012 | - | $69.40 K(+11.0%) | $234.10 K(+12.4%) |
| Mar 2012 | - | $62.50 K(+13.2%) | $208.30 K(+30.8%) |
| Dec 2011 | $159.20 K(+580.3%) | $55.20 K(+17.4%) | $159.20 K(+44.1%) |
| Sep 2011 | - | $47.00 K(+7.8%) | $110.50 K(+57.9%) |
| Jun 2011 | - | $43.60 K(+225.4%) | $70.00 K(+114.1%) |
| Mar 2011 | - | $13.40 K(+106.2%) | $32.70 K(+39.1%) |
| Dec 2010 | $23.40 K(+735.7%) | $6500.00(0.0%) | $23.50 K(+38.2%) |
| Sep 2010 | - | $6500.00(+3.2%) | $17.00 K(+61.9%) |
| Jun 2010 | - | $6300.00(+50.0%) | $10.50 K(+150.0%) |
| Mar 2010 | - | $4200.00 | $4200.00 |
| Dec 2009 | $2800.00 | - | - |
FAQ
- What is Sorrento Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual D&A year-on-year change?
- What is Sorrento Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly D&A year-on-year change?
- What is Sorrento Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Sorrento Therapeutics?
- What is Sorrento Therapeutics TTM D&A year-on-year change?
What is Sorrento Therapeutics annual depreciation & amortization?
The current annual D&A of SRNE is $13.24 M
What is the all time high annual D&A for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual depreciation & amortization is $13.24 M
What is Sorrento Therapeutics annual D&A year-on-year change?
Over the past year, SRNE annual depreciation & amortization has changed by +$783.00 K (+6.28%)
What is Sorrento Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of SRNE is $3.59 M
What is the all time high quarterly D&A for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly depreciation & amortization is $3.62 M
What is Sorrento Therapeutics quarterly D&A year-on-year change?
Over the past year, SRNE quarterly depreciation & amortization has changed by -$30.00 K (-0.83%)
What is Sorrento Therapeutics TTM depreciation & amortization?
The current TTM D&A of SRNE is $13.93 M
What is the all time high TTM D&A for Sorrento Therapeutics?
Sorrento Therapeutics all-time high TTM depreciation & amortization is $13.93 M
What is Sorrento Therapeutics TTM D&A year-on-year change?
Over the past year, SRNE TTM depreciation & amortization has changed by +$357.00 K (+2.63%)